AARP Eye Center
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
WASHINGTON—Today AARP released the findings of a nationwide poll that explores the priorities and concerns of a key group of voters that could help determine the 2020 presidential election and...
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement on today’s vote by the U.S. House of Representatives on H.R....
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement urging the U.S. House of Representatives to vote in support of...
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement in response to the patent protections for biologic drugs and...
WASHINGTON—AARP Senior Vice President for Government Affairs Bill Sweeney released the following statement calling on Congress to extend and make permanent the medical expense deduction before...
WASHINGTON—AARP is pleased to announce that the National Kidney Foundation (NKF) and the Johns Hopkins Armstrong Institute for Patient Safety and Quality are the winners of the 2019 AARP Quality...
WASHINGTON — Approximately 41 million unpaid family caregivers provided an estimated 34 billion hours of care — worth a staggering $470 billion — to their parents, spouses, partners, and...
WASHINGTON—Retail prices for 267 brand-name drugs commonly used by older adults surged by an average of 5.8% in 2018, more than twice the general inflation rate of 2.4%, according to new AARP...
WASHINGTON—AARP Senior Vice President for Government Affairs Bill Sweeney released the following statement on the approval by the United States House of Representatives of H.R. 4334, the Dignity...
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement on today’s markup of H.R. 3, the Lower Drug Costs Now Act of...